The Journal of Practical Medicine >

2024 , Vol. 40 >Issue 14: 2003 - 2008

DOI: https://doi.org/10.3969/j.issn.1006-5725.2024.14.017

Medical Examination and Clinical Diagnosis

Differential diagnostic value of wide⁃body spectral CT parameters in mediastinal metastatic， non⁃metastatic lymph nodes of lung cancer patients and reactive hyperplastic lymph nodes

  • Sijie ZHENG ,
  • Jia XIANG ,
  • Qiantong CHEN ,
  • Yingxin LU ,
  • Yun LIU ,
  • Huai CHEN ,
  • Suidan. HUANG
Expand
  • *.Department of Radiology，the Second Affiliated Hospital of Guangzhou Medical University，Guangzhou 510260，China
    *.Guangzhou Medical University，Guangzhou 510182，China

Received date: 2024-03-27

  Online published: 2024-07-15

Fold

Abstract

Objective The evaluation of lymph node properties before lung cancer surgery has a great impact with the choice of surgical methods. Although there are various examination methods， many methods have invasive or accuracy problems. In order to improve the accuracy of diagnosis， we mainly discuss the value of wide?body spectral CT in the differential diagnosis of mediastinal metastatic lymph nodes， non?metastatic lymph nodes in lung cancer patients and reactive hyperplastic lymph nodes. Methods The clinical and imaging data of 64 patients with lung cancer and 28 patients with pulmonary inflammatory lesions were retrospectively analyzed. All patients underwent plain scan and enhanced dual?phase spectral CT scan. The size， density， three?phase IC， NIC， and λHU of lymph nodes in metastatic， non?metastatic and inflammatory reactive hyperplasia groups were measured on 70 keV single?energy images and iodine?based images， respectively. The single?factor variance and Kruskal?Wallis H rank sum test were used to analyze and compare the differences. Results The short diameter of metastatic lymph nodes was larger than that of non?metastatic lymph nodes and reactive hyperplastic lymph nodes （P < 0.001）. The plain scan density of reactive hyperplastic lymph nodes was higher than that of metastatic lymph nodes （P < 0.001）， but there was no significant difference between non?metastatic lymph nodes （P = 0.325）. The CT values of reactive hyperplastic lymph nodes in arterial phase and venous phase were higher than those of metastatic and non?metastatic lymph nodes （P < 0.05）. Except for NIC in arterial phase， IC， NIC and λHU in plain scan， IC and λHU in arterial phase， IC， NIC and λHU in venous phase of reactive hyperplastic lymph nodes and metastatic lymph nodes were statistically significant （all P < 0.05）. There was no significant difference in IC， NIC and λHU between reactive hyperplastic lymph nodes and non?metastatic lymph nodes in plain scan， arterial phase and venous phase （all P > 0.05）. Conclusion The quantitative and spectral curve slope of iodine in mediastinal metastatic lymph nodes of lung cancer were basically lower than those in reactive hyperplastic lymph nodes. The quantitative parameters of spectral CT had certain diagnostic efficacy in differentiating metastatic lymph nodes and reactive hyperplastic lymph nodes， while the spectral parameters of non?metastatic lymph nodes and reactive hyperplastic lymph nodes were not statistically significant.

Key words： lung cancer; mediastinal lymph nodes; spectral CT; efficiency

Cite this article

Sijie ZHENG , Jia XIANG , Qiantong CHEN , Yingxin LU , Yun LIU , Huai CHEN , Suidan. HUANG . Differential diagnostic value of wide⁃body spectral CT parameters in mediastinal metastatic， non⁃metastatic lymph nodes of lung cancer patients and reactive hyperplastic lymph nodes[J]. The Journal of Practical Medicine, 2024 , 40(14) : 2003 -2008 . DOI: 10.3969/j.issn.1006-5725.2024.14.017

References

1 SUNG H， FERLAY J， SIEGEL R L， et al. Global Cancer Statistics 2020： GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries ［J］. CA Cancer J Clin， 2021， 71（3）： 209-249. doi:10.3322/caac.21660
2 YANG T， XIONG Y， ZENG Y， et al. Current status of immunotherapy for non-small cell lung cancer ［J］. Front Pharmacol， 2022， 13： 989461. doi:10.3389/fphar.2022.989461
3 SONG H， YOON S H， KIM J， et al. Application of N Descriptors Proposed by the International Association for the Study of Lung Cancer in Clinical Staging ［J］. Radiology， 2021， 300（2）： 450-457. doi:10.1148/radiol.2021204461
4 WANG H， LI Q K， AUSTER M， et al. PET and CT features differentiating infectious/inflammatory from malignant mediastinal lymphadenopathy： A correlated study with endobronchial ultrasound-guided transbronchial needle aspiration ［J］. Radiol Infect Dis， 2018， 5（1）： 7-13. doi:10.1016/j.jrid.2018.01.002
5 YANG S Y， SHIN J H， HAHN S Y， et al. Comparison of ultrasonography and CT for preoperative nodal assessment of patients with papillary thyroid cancer： diagnostic performance according to primary tumor size ［J］. Acta Radiol， 2020， 61（1）： 21-27. doi:10.1177/0284185119847677
6 WU Y Y， WEI C， WANG C B， et al. Preoperative Prediction of Cervical Nodal Metastasis in Papillary Thyroid Carcinoma： Value of Quantitative Dual-Energy CT Parameters and Qualitative Morphologic Features ［J］. AJR Am J Roentgenol， 2021， 216（5）： 1335-1343. doi:10.2214/ajr.20.23516
7 LEE S W， KIM S J. Is Delayed Image of 18F-FDG PET/CT Necessary for Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer Patients？ ［J］. Clin Nucl Med， 2022， 47（5）： 414-421. doi:10.1097/rlu.0000000000004110
8 李雪蓉， 肖雄， 冯洪燕， 等. 18F-FDG PET/CT非小细胞肺癌原发灶代谢参数和纵隔淋巴结SUVmax预测纵隔淋巴结转移的价值 ［J］. 实用医学杂志， 2019， 35（23）： 3676-3680. doi:10.3969/j.issn.1006-5725.2019.23.020
9 ENDOH H， YAMAMOTO R， ICHIKAWA A， et al. Clinicopathologic Significance of False-Positive Lymph Node Status on FDG-PET in Lung Cancer ［J］. Clin Lung Cancer， 2021， 22（3）： 218-224. doi:10.1016/j.cllc.2020.05.002
10 NAGANO H， TAKUMI K， NAKAJO M， et al. Dual-Energy CT-Derived Electron Density for Diagnosing Metastatic Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer： Comparison With Conventional CT and FDG PET/CT Findings ［J］. AJR Am J Roentgenol， 2022， 218（1）： 66-74. doi:10.2214/ajr.21.26208
11 AGOSTINI A， BORGHERESI A， MARI A， et al. Dual-energy CT： theoretical principles and clinical applications ［J］. Radiol Med， 2019， 124（12）： 1281-1295. doi:10.1007/s11547-019-01107-8
12 GREFFIER J， VILLANI N， DEFEZ D， et al. Spectral CT imaging： Technical principles of dual-energy CT and multi-energy photon-counting CT ［J］. Diagn Interv Imaging， 2023， 104（4）： 167-177. doi:10.1016/j.diii.2022.11.003
13 WANG T， FAN Z， ZOU L， et al. Can quantitative parameters of spectral computed tomography predict lymphatic metastasis in lung cancer？ a systematic review and meta-analysis ［J］. Radiother Oncol， 2023， 183： 109643. doi:10.1016/j.radonc.2023.109643
14 CHEN M， JIANG Y， ZHOU X， et al. Dual-Energy Computed Tomography in Detecting and Predicting Lymph Node Metastasis in Malignant Tumor Patients： A Comprehensive Review ［J］. Diagnostics （Basel）， 2024， 14（4）：377. doi:10.3390/diagnostics14040377
15 LI X， MENG X， YE Z. Iodine quantification to characterize primary lesions， metastatic and non-metastatic lymph nodes in lung cancers by dual energy computed tomography： An initial experience ［J］. Eur J Radiol， 2016， 85（6）： 1219-1223. doi:10.1016/j.ejrad.2016.03.030
16 ASAMURA H， CHANSKY K， CROWLEY J， et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project： Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer ［J］. J Thorac Oncol， 2015， 10（12）： 1675-1684. doi:10.1097/jto.0000000000000678
17 GOLDSTRAW P， CHANSKY K， CROWLEY J， et al. The IASLC Lung Cancer Staging Project： Proposals for Revision of the TNM Stage Groupings in the Forthcoming （Eighth） Edition of the TNM Classification for Lung Cancer ［J］. J Thorac Oncol， 2016， 11（1）： 39-51. doi:10.1016/j.jtho.2015.09.009
18 ADEGUNSOYE A， OLDHAM J M， BONHAM C， et al. Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation ［J］. Am J Respir Crit Care Med， 2019， 199（6）： 747-759. doi:10.1164/rccm.201804-0761oc
19 WILLARD-MACK C L. Normal structure， function， and histology of lymph nodes ［J］. Toxicol Pathol， 2006， 34（5）： 409-424. doi:10.1080/01926230600867727
20 ALIZADEH L S， VOGL T J， WALDECK S S， et al. Dual-Energy CT in Cardiothoracic Imaging： Current Developments ［J］. Diagnostics （Basel）， 2023， 13（12）：2116. doi:10.3390/diagnostics13122116
21 GRECUCCIO S， SVERZELLATI N， USLENGHI E， et al. Prognostic value of mediastinal lymph node enlargement in chronic interstitial lung disease ［J］. Diagn Interv Radiol， 2021， 27（3）： 329-335. doi:10.5152/dir.2021.19585
22 TAWFIK A M， RAZEK A A， KERL J M， et al. Comparison of dual-energy CT-derived iodine content and iodine overlay of normal， inflammatory and metastatic squamous cell carcinoma cervical lymph nodes ［J］. Eur Radiol， 2014， 24（3）： 574-580. doi:10.1007/s00330-013-3035-3
23 FEHRENBACH U， FELDHAUS F， KAHN J， et al. Tumour response in non-small-cell lung cancer patients treated with chemoradiotherapy - Can spectral CT predict recurrence？ ［J］. J Med Imaging Radiat Oncol， 2019， 63（5）： 641-649. doi:10.1111/1754-9485.12926
24 顾艳， 苗重昌， 袁刚， 等. 肺癌双能量成像、微血管密度和血管内皮生长因子与淋巴结转移的关系 ［J］. 实用医学杂志， 2018， 34（6）： 1019-1022. doi:10.3969/j.issn.1006-5725.2018.06.036
25 梁百晖， 杨文， 刘岘， 等. 双层探测器光谱CT对直肠腺癌转移淋巴结的诊断价值 ［J］. 实用医学杂志， 2023， 39（3）： 374-380. doi:10.3969/j.issn.1006-5725.2023.03.020
26 ZHANG L J， WU S， WANG M， et al. Quantitative dual energy CT measurements in rabbit VX2 liver tumors： Comparison to perfusion CT measurements and histopathological findings ［J］. Eur J Radiol， 2012， 81（8）： 1766-1775. doi:10.1016/j.ejrad.2011.06.057
27 GAO L， LU X， WEN Q， et al. Added value of spectral parameters for the assessment of lymph node metastasis of lung cancer with dual-layer spectral detector computed tomography ［J］. Quant Imaging Med Surg， 2021， 11（6）： 2622-2633. doi:10.21037/qims-20-1045
Options
Outlines

/

〈 〉